Ad
related to: AKBA Stock
Search results
Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year?
Zacks via Yahoo Finance· 11 months agoInvestors interested in Medical stocks should always be looking to find the best-performing...
Unveiling Akebia Therapeutics (AKBA)'s Value: Is It Really Priced Right? A Comprehensive Guide
GuruFocus.com via Yahoo Finance· 9 months agoWith a daily gain of 15.57% and a 3-month gain of 13.19%, Akebia Therapeutics Inc (NASDAQ:AKBA) has...
Akebia Therapeutics (AKBA) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoAkebia Therapeutics (AKBA) delivered earnings and revenue surprises of -86.67% and 3.80%,...
All You Need to Know About Akebia Therapeutics (AKBA) Rating Upgrade to Buy
Zacks via Yahoo Finance· 12 months agoAkebia Therapeutics (AKBA) might move higher on growing optimism about its earnings prospects, which...
Akebia Therapeutics (AKBA) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Zacks via Yahoo Finance· 7 months agoAkebia Therapeutics (AKBA) doesn't possess the right combination of the two key ingredients for a...
Akebia Therapeutics (NASDAQ:AKBA) shareholders have earned a 265% return over the last year
Simply Wall St. via Yahoo Finance· 5 months agoIt hasn't been the best quarter for Akebia Therapeutics, Inc. (NASDAQ:AKBA) shareholders, since the...
Akebia Therapeutics (NASDAQ:AKBA) shareholder returns have been splendid, earning 188% in 1 year
Simply Wall St. via Yahoo Finance· 12 months agoThe most you can lose on any stock (assuming you don't use leverage) is 100% of your money. On the...
Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD
Zacks via Yahoo Finance· 2 months agoAkebia (AKBA) gains during premarket hours on Mar 28 as its key product Vafseo (vadadustat) tablets...
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 weeks agoAkebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript May 9, 2024 Akebia...
Is Akebia Therapeutics Inc (AKBA) Set to Underperform? Analyzing the Factors Limiting Growth
GuruFocus.com via Yahoo Finance· 9 months agoLong-established in the Biotechnology industry, Akebia Therapeutics Inc (NASDAQ:AKBA) has enjoyed a...
